Nomogram predicting survival as a selection criterion for postmastectomy radiotherapy in patients with T1 to T2 breast cancer with 1 to 3 positive lymph nodes

被引:18
作者
Tang, Yu [1 ,2 ]
Zhang, Yu-Jing [3 ]
Zhang, Na [4 ]
Shi, Mei [5 ]
Wen, Ge [6 ]
Cheng, Jing [7 ]
Wang, Hong-Mei [8 ]
Liu, Min [9 ]
Wang, Xiao-Hu [10 ]
Guo, Qi-Shuai [11 ]
Wu, Hong-Fen [12 ]
Ma, Chang-Ying [13 ]
Jin, Jing [1 ,2 ]
Liu, Yue-Ping [1 ,2 ]
Song, Yong-Wen [1 ,2 ]
Fang, Hui [1 ,2 ]
Ren, Hua [1 ,2 ]
Wang, Shu-Lian [1 ,2 ]
Li, Ye-Xiong [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, State Key Lab Mol Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Panjiayuan Nanli 17, Beijing 100021, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Radiat Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Panjiayuan Nanli 17, Beijing 100021, Peoples R China
[3] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Radiat Oncol, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China
[4] China Med Univ, Liaoning Canc Hosp & Inst, Canc Hosp, Dept Radiat Oncol, Shenyang, Peoples R China
[5] Fourth Mil Med Univ, Xijing Hosp, Dept Radiat Oncol, Xian, Peoples R China
[6] Guangzhou Med Univ, Dept Radiat Oncol, Affiliated Hosp 3, Guangzhou, Peoples R China
[7] Huazhong Univ Sci & Technol, Dept Breast Oncol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China
[8] Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Peoples R China
[9] First Hosp Jilin Univ, Dept Radiat Oncol, Changchun, Peoples R China
[10] Gansu Canc Hosp, Dept Radiat Oncol, Lanzhou, Peoples R China
[11] Chongqing Univ, Chongqing Canc Hosp, Chongqing Canc Inst, Dept Radiat Oncol,Canc Hosp, Chongqing, Peoples R China
[12] Jilin Canc Hosp, Dept Radiat Oncol, Changchun, Peoples R China
[13] First Hosp Qiqihaer, Dept Radiat Oncol, Qiqihar, Peoples R China
关键词
breast neoplasm; mastectomy; N1; nomogram; radiotherapy; LOCOREGIONAL RECURRENCE RISK; POSTOPERATIVE RADIOTHERAPY; PREMENOPAUSAL WOMEN; CLINICAL ONCOLOGY; AMERICAN SOCIETY; MASTECTOMY; CHEMOTHERAPY; MULTICENTER; IRRADIATION; RADIATION;
D O I
10.1002/cncr.32963
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The role of postmastectomy radiotherapy (PMRT) in women with pT1-T2N1 breast cancer is controversial. The authors developed a nomogram that was predictive for overall survival (OS) and identified patients who derived no benefit from PMRT. Methods The authors retrospectively evaluated 4869 patients with pT1-T2N1 breast cancer who were treated with mastectomy between 2000 and 2014 in 11 Chinese hospitals. Rates of locoregional recurrence and distant metastasis were calculated using competing risk analysis, and disease-free survival and OS rates were calculated using the Kaplan-Meier method. Based on the risk factors identified from Cox regression analysis in 3298 unirradiated patients, a nomogram predicting OS was developed. The benefit of PMRT was evaluated in different risk groups stratified by the nomogram model. Results After a median follow-up of 65.9 months, the 5-year OS, disease-free survival, locoregional recurrence, and distant metastasis rates were 93.3%, 84.3%, 5.2%, and 8.3%, respectively. A total of 1571 patients (32.3%) underwent PMRT. On multivariable analyses, PMRT was found to increase OS significantly (hazard ratio, 0.61;P = .002). An OS prediction nomogram evaluated the effect of age; tumor location; tumor size; positive lymph node ratio; estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status; and treatment with trastuzumab. Based on nomogram scores, the entire patient cohort was classified into 3 risk groups. PMRT significantly improved the OS of patients in the intermediate-risk (P < .001) and high-risk groups (P = .004), but not in the low-risk group (P = .728). Conclusions The authors developed a nomogram that is predictive of OS among women with pT1-T2N1 breast cancer after mastectomy. This nomogram may help to select a subgroup of patients with a good prognosis who will not benefit from PMRT.
引用
收藏
页码:3857 / 3866
页数:10
相关论文
共 50 条
  • [21] Post Mastectomy Radiation For Stage II Breast Cancer Patients with T1/T2 Lesions
    Libson, Shai
    Perez, Eduardo
    Takita, Christiane
    Avisar, Eli
    [J]. EUROPEAN JOURNAL OF BREAST HEALTH, 2019, 15 (02) : 71 - 75
  • [22] Post-Mastectomy Radiotherapy for Breast Cancer Patients with T1-T2 and 1-3 Positive Lymph Nodes: a Meta-Analysis
    Li, Yaming
    Moran, Meena S.
    Huo, Qiang
    Yang, Qifeng
    Haffty, Bruce G.
    [J]. PLOS ONE, 2013, 8 (12):
  • [23] Postmastectomy irradiation in breast in breast cancer patients with T1-2 and 1-3 positive axillary lymph nodes: Is there a role for radiation therapy?
    Cosar, Rusen
    Uzal, Cem
    Tokatli, Fusun
    Denizli, Bengu
    Saynak, Mert
    Turan, Nesrin
    Uzunoglu, Sernaz
    Ozen, Alaattin
    Sezer, Atakan
    Ibis, Kamuran
    Uregen, Burcu
    Yurut-Caloglu, Vuslat
    Kocak, Zafer
    [J]. RADIATION ONCOLOGY, 2011, 6
  • [24] Postmastectomy radiotherapy benefit in Chinese breast cancer patients with T1-T2 tumor and 1-3 positive axillary lymph nodes by molecular subtypes: an analysis of 1369 cases
    Shen, Honghong
    Zhao, Lin
    Wang, Li
    Liu, Xiaozhen
    Liu, Xia
    Liu, Junjun
    Niu, Fengting
    Lv, Shuhua
    Niu, Yun
    [J]. TUMOR BIOLOGY, 2016, 37 (05) : 6465 - 6475
  • [25] Postmastectomy Radiotherapy Improves Disease-Free Survival of High Risk of Locoregional Recurrence Breast Cancer Patients with T1-2 and 1 to 3 Positive Nodes
    He, Zhen-Yu
    Wu, San-Gang
    Zhou, Juan
    Li, Fang-Yan
    Lin, Qin
    Lin, Huan-Xin
    Sun, Jia-Yuan
    [J]. PLOS ONE, 2015, 10 (03):
  • [26] A nomogram based on the log odds of positive lymph nodes for predicting the prognosis of T1 stage rectal cancer
    Guo, Zixiang
    Li, Weihua
    Wu, Kaini
    Fu, Yunfeng
    Yan, Runwei
    Zhou, Xiaodong
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (04): : 1498 - +
  • [27] The role of different lymph node staging systems in predicting prognosis and determining indications for postmastectomy radiotherapy in patients with T1-T2pN1 breast carcinoma
    Kustic, Domagoj
    Gembic, Tihana Klarica
    Grebic, Damir
    Majnaric, Silvana Petretic
    Nekic, Jasna
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (11) : 1044 - 1054
  • [28] Real-world outcomes of postmastectomy radiotherapy in breast cancer patients with 1-3 positive lymph nodes: a retrospective study
    Chitapanarux, Imjai
    Tharavichitkul, Ekkasit
    Jakrabhandu, Somvilai
    Klunklin, Pitchayaponne
    Onchan, Wimrak
    Srikawin, Jirawattana
    Pukanhaphan, Nantaka
    Traisathit, Patrinee
    Vongtama, Roy
    [J]. JOURNAL OF RADIATION RESEARCH, 2014, 55 (01) : 121 - 128
  • [29] Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial
    Zeidan, Youssef H.
    Habib, Joyce G.
    Ameye, Lieveke
    Paesmans, Marianne
    de Azambuja, Evandro
    Gelber, Richard D.
    Campbell, Ian
    Nordenskjold, Bo
    Gutierez, Jorge
    Anderson, Michael
    Lluch, Ana
    Gnant, Michael
    Goldhirsch, Aron
    Di Leo, Angelo
    Joseph, David J.
    Crown, John
    Piccart-Gebhart, Martine
    Francis, Prudence A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (02): : 316 - 324
  • [30] Impact of Molecular Subtype on Locoregional Recurrence in Mastectomy Patients with T1-T2 Breast Cancer and 1-3 Positive Lymph Nodes
    Moo, Tracy-Ann
    McMillan, Robert
    Lee, Michele
    Stempel, Michelle
    Ho, Alice
    Patil, Sujata
    El-Tamer, Mahmoud
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (05) : 1569 - 1574